載入...
Rebound Hypercalcemia After Denosumab Therapy in a Child With Cherubism
Background: Cherubism, caused by autosomal dominant mutations in the SH3BP2 gene, is characterized by increased bone resorption with development of bilateral fibro-osseous lesions limited to the maxilla and mandible. The SH3BP2 gene is thought to be involved in osteoclastogenesis. Affected children,...
Na minha lista:
| 發表在: | J Endocr Soc |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Oxford University Press
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8089366/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab048.442 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|